Equillium, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
EQ$1.46-3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders' Equity
(In thousands, except share data)
| Additional · AccumulatedOther · Total | ||||||
|---|---|---|---|---|---|---|
| Common Stock · Paid-in · Comprehensive · Accumulated · Stockholders' | ||||||
| Shares | Amount | Capital | Income | Deficit | Equity | |
| Balance at December 31, 2023 | 35,254,752 | $3 | $208,170 | $140 | $(185,740) | $22,573 |
| Stock-based compensation expense | - | - | 972 | - | - | 972 |
| Other comprehensive income | - | - | - | 283 | - | 283 |
| Net loss | - | - | - | - | (2,734) | (2,734) |
| Balance at March 31, 2024 | 35,254,752 | $3 | $209,142 | $423 | $(188,474) | $21,094 |
| Issuance of common stock under employee stock purchase plan | 169,636 | - | 91 | - | - | 91 |
| Stock-based compensation expense | - | - | 952 | - | - | 952 |
| Other comprehensive loss | - | - | - | (172) | - | (172) |
| Net income | - | - | - | - | 468 | 468 |
| Balance at June 30, 2024 | 35,424,388 | $3 | $210,185 | $251 | $(188,006) | $22,433 |
| Stock-based compensation expense | - | - | 1,005 | - | - | 1,005 |
| Other comprehensive loss | - | - | - | (254) | - | (254) |
| Net loss | - | - | - | - | (7) | (7) |
| Balance at September 30, 2024 | 35,424,388 | $3 | $211,190 | $(3) | $(188,013) | $23,177 |
| Additional · AccumulatedOther · Total | ||||||
| Common Stock · Paid-in · Comprehensive · Accumulated · Stockholders' | ||||||
| Shares | Amount | Capital | Income | Deficit | Equity | |
| Balance at December 31, 2024 | 35,557,563 | $3 | $212,084 | $781 | $(193,807) | $19,061 |
| Stock-based compensation expense | - | - | 621 | - | - | 621 |
| Exercise of stock options | 52,344 | - | 38 | - | - | 38 |
| Issuance of common stock under ATM, net of issuance costs | 109,410 | - | (438) | - | - | (438) |
| Other comprehensive loss | - | - | - | (50) | - | (50) |
| Net loss | - | - | - | - | (8,654) | (8,654) |
| Balance at March 31, 2025 | 35,719,317 | $3 | $212,305 | $731 | $(202,461) | $10,578 |
| Stock-based compensation expense | - | - | 563 | - | - | 563 |
| Other comprehensive loss | - | - | - | (346) | - | (346) |
| Net loss | - | - | - | - | (5,739) | (5,739) |
| Balance at June 30, 2025 | 35,719,317 | $3 | $212,868 | $385 | $(208,200) | $5,056 |
| Stock-based compensation expense | - | - | 401 | - | - | 401 |
| Exercise of stock options | 1,532,571 | - | 1,191 | - | - | 1,191 |
| Issuance of common stock under ATM, net of issuance costs | 1,610,075 | - | 727 | - | - | 727 |
| Issuance of common stock under private placement of equity securities, net of issuance costs | 21,814,874 | 2 | 27,907 | - | - | 27,909 |
| Other comprehensive loss | - | - | - | (115) | - | (115) |
| Net loss | - | - | - | - | (4,230) | (4,230) |
| Balance at September 30, 2025 | 60,676,837 | $5 | $243,094 | $270 | $(212,430) | $30,939 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.